Novo Nordisk A/S News Headlines

NVO 
$45.91
*  
0.44
0.97%
Get NVO Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sanofi's LixiLan Progresses - Analyst Blog
1/16/2014 7:20:01 PM - Zacks.com

Cramer's Lightning Round - TiVo's Downgrade Had Gravitas (1/14/13)
1/15/2014 6:01:00 AM - Seeking Alpha

Pre-Market Most Active for Jan 10, 2014 : NOK, BAC, AA, QQQ, TGT, INFY, NVO, CNAT, MNKD, FB, XIV, MSFT
1/10/2014 9:38:58 AM - NASDAQ.com News

Novo Nordisk A/S (NVO) Enters Overbought Territory - Tale of the Tape
1/6/2014 9:51:01 AM - Zacks.com

U.S. Approval for NVO's Tretten - Analyst Blog
12/27/2013 12:02:10 PM - Zacks.com

Arena Pharmaceuticals - A 2014 Story
12/26/2013 4:14:00 PM - Seeking Alpha

Update on NVO's Victoza - Analyst Blog
12/26/2013 1:10:01 PM - Zacks.com

The Obesity Drug Industry Going Into 2014
12/26/2013 6:24:00 AM - Seeking Alpha

Diabetes Programs Now Crucial For Eli Lilly
12/23/2013 8:15:00 AM - Seeking Alpha

An Analysis Of Unilife's Products Shows A Weak Business Case
12/13/2013 9:01:00 AM - Seeking Alpha

Sanofi's Update on Lyxumia - Analyst Blog
12/10/2013 3:23:26 PM - Zacks.com

European Shares Drop on Weak French Data, Fed Worries
12/10/2013 1:33:54 PM - MT Newswires

Positive Phase III Data on Sanofi's U300 - Analyst Blog
12/4/2013 6:05:24 PM - Zacks.com

Data on NVO's Diabetes Drugs - Analyst Blog
12/4/2013 5:04:51 PM - Zacks.com

Update on Glaxo's Avandia - Analyst Blog
11/27/2013 7:06:14 PM - Zacks.com

Update on AstraZeneca's Diabetes Portfolio - Analyst Blog
11/26/2013 5:06:04 PM - Zacks.com

Diabetes Portfolio Update from Novo Nordisk - Analyst Blog
11/25/2013 4:05:57 PM - Zacks.com

Roche's Gazyva Approved in the U.S. - Analyst Blog
11/7/2013 7:39:01 PM - Zacks.com

Stock Upgrades: Green Ink for Green Dot and Greenbrier
11/1/2013 9:18:00 AM - Minyanville

Novo Nordisk Beats on Earnings, Lags Sales - Analyst Blog
11/1/2013 9:13:01 AM - Zacks.com

European Shares Narrowly Mixed, Earnings Help Offset More Hawkish Fed
10/31/2013 12:07:46 PM - MT Newswires

Time To Consider Investing In Scandinavia (EWD, EFNL, NORW, EDEN, GXF)
10/25/2013 3:16:47 PM - Benzinga

FDA Approves Novo Nordisk's NovoEight - Analyst Blog
10/18/2013 5:07:25 PM - Zacks.com

Update on VIVUS' Qsymia - Analyst Blog
10/14/2013 11:40:01 AM - Zacks.com

GSK, Genmab Seek Arzerra EU Approval - Analyst Blog
10/7/2013 5:31:01 PM - Zacks.com